Khushbakat Mittal, MD

Department of Obstetric and Gynecologic Pathology
NYU Medical Center
New York University School of Medicine
New York, NY, USA



• (2002-Present) Director, Obstetric and Gynecologic Pathology, NYU Medical center, New York University School of Medicine, New York, NY
• (2015-Present) Program Director, Fellowship program in Womens Pathology
• (2002-2015) Program Director, Fellowship program in Obstetric and Gynecologic Pathology
• (1994-Present) Associate Professor of Surgical Pathology, Associate Attending in Pathology, New York University School of Medicine, New York University Medical Center, Tisch and Bellevue Hospitals, New York, NY
• (2003-2009) Director, Surgical Pathology, Bellevue Hospital, New York University School of Medicine, New York, NY
• (1989-2002) Director, In situ hybridization lab., Bellevue Hospital, New York, NY
• (1994-2002) Associate Director of Gynecologic Pathology, New York University School of Medicine, New York University Medical Center, Tisch and Bellevue Hospitals, New York, NY
• (1988-1990) Director, Immunohistochemistry lab., Bellevue Hospital, New York
• (1987-1994) Assistant Professor of Pathology, New York University School of Medicine, New York University Medical Center, Tisch and Bellevue Hospitals, New York, NY
• (1986-1987) Fellow in Surgical Pathology with Dr. Juan Rosai at Yale New Haven Medical Center and Yale University School of Medicine, New Haven, CT
• (7/85-7/86) Chief Resident, Anatomic Pathology, Yale New Haven Hospital and Yale University School of Medicine, New Haven, CT
• (7/82-6/85) Pathology Resident, Anatomic Pathology, State University of New York at Buffalo affiliated hospitals including Roswell Park Memorial Institute, Buffalo, NY
• (7/81-6/82) Internship, Warren State Hospital, Warren, PA
• (4/80-5/81) Pathology Registrar, Anatomic Pathology, Auckland Hospital Board Auckland, New Zealand
• (1/78-3/80) Pathology Residency, Anatomic and Clinical Pathology, All India Institute of Medical Sciences, New Delhi, India

Research Interest

His research interests include: Gynecologic Obstetric Pathology; Surgical Pathology; Placental, Cervical, Uterine and Ovarian Pathology; In situ hybridization; Immunohistochemistry; Lab Management and Quality Improvement.

Scientific Activities


• Association of Directors of Anatomic and Clinical Pathology
• International Association of Gynecologic Pathologists
• United States and Canadian Academy of Pathologists


1. Mittal KR, Chopra P. Primary fibrous histiocytoma of the pericardium. Indian Journal of Pathology and Microbiology. 1982; 25: 157-160.
2. Mittal KR, Olszewski WA. Widening of interpurkinje cell distances in association with corpora amylacea. Journal of Gerontology. 1985; 40: 6: 700 704.
3. Mittal KR, Gerald W, True L. Hemangiopericytoma of breast: An ultrastructural and immunohistochemical study. Human Pathology. 1986; 17: 1181 1183.
4. Mittal KR, Miller KA, Lowell DM. Koilocytosis preceding squamous cell carcinoma in situ of the uterine cervix. Am J Clin Path. 1987; 87(2): 243 245.
5. Mittal KR, Logmani F. Age related reduction in 8th ventral nerve root medullated fibre numbers and diameters in man. Journal of Gerontology. 1987; 42: 8 10.
6. Mittal KR, Barwick KW, Schwartz PE. Architectural grading, nuclear grading, and other prognostic indicators in endometrial carcinoma with identification of a low and a high risk group. Cancer. 1988; 61: 538 545. doi: 10.1002/1097-0142(19880201)61:3<538::AID-CNCR2820610320>3.0.CO;2-G
7. Mittal KR, True L. The origin of granules in granular cell tumor: Intracellular myelin formations with autodigestion. Arch Path and Lab Med. 1988; 112: 302 303.
8. Young N, Damien M, Schwartz PE, Carter DE, Mittal KR. Carcinosarcoma of the uterine cervix initially interpreted as high grade sarcoma. A case report with immunohistochemical findings. Human Pathology. 1988; 19: 605 608.
9. Kacinski BM, Carter D, Mittal KR, et al. High level expression of FMS proto oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinoma. Int J Radiation Oncology Biol Phy. 1988; 15: 823 829. doi: 10.1016/0360-3016(88)90113-7
10. Mittal KR, Barwick KW. Diffuse infiltrating adenocarcinoma of endometrium: A subtype with poor prognosis. Am J Surg Path. 1988; 12(10): 754 758.
11. Auerbach R, Mittal KR, Schwartz PE. Estrogen and Progesterone receptors in an ovarian ependymoma. Obstetrics and Gynecology. 1988; 71(6): 1043 1045.
12. Kacinski BM, Carter D, Kohorn EI, Mittal KR, et al. Oncogene expression in vivo by ovarian adenocarcinoma and mixed Mullerian tumors. The Yale Journal of Biology and Medicine. 1989; 62: 379 392.
13. Mittal KR, Neri A, Feiner H, Schinella RA, Alfonso F. Lymphomatoid granulomatosis in AIDS: Evidence of EBV infection and clonal selection without myc rearrangement. Cancer. 1990; 65: 1345 1349.
14. Sculerati N, Mittal KR, Greco MA, Ambrosino MM. Fibrous Histiocytoma of the Trachea. International Journal of Pediatric Otorhinolaryngology. 1990; 19: 295 301.
15. Mittal KR, Pearson J, Demopoulos RI. Patterns of Keratin B2 and EGFR mRNA expression in normal cervical epithelium and in Cervical Intraepithelial Neoplasia. Gynecologic Oncology. 1990; 38: 224 229.
16. Kacinski BM, Carter DE, Mittal KR, et al. Ovarian Adenocarcinomas express FMS complimentary Transcripts and FMS antigen often with co expression of CSF 1. Am J Pathol. 1990; 137(1): 135 147.
17. Mittal KR, Chan W, Demopoulos RI. Sensitivity and specificity of various morphologic features of cervical condylomas: An In situ hybridization study. Arch Path Lab Med. 1990; 114(10): 1038 1041.
18. Chandwani S, Greco MA, Mittal KR, Antoine C, Kracinski K, Borokowsky W. Pathology and HIV expression in term placentas from seropositive women. The Journal of Infectious Diseases. 1990; 163(5): 1134 1138.
19. Aparicio Duque R, Mittal KR, Schinella RA, Pearson J, Chan W. Cloacogenic Carcinoma of Anal Canal and associated viral lesions : An In situ hybridization study. Cancer. 1990; 68: 2422 2425.
20. Obiakor I, Maiman M, Mittal KR, Awobuluyi M, DiMao T, Demopoulos RI. The accuracy of frozen section in the diagnosis of Ovarian neoplasms. Gynecologic Oncology. 1991; 43: 61 63.
21. Yang GCH, Demopoulos RI, Chan W, Mittal KR. Superficial nuclear enlargement without koilocytosis as an expression of HPV infection of the uterine cervix: An In situ hybridization study. Int J Gynecol Pathol. 1992; 11: 283 287.
22. Mittal KR, Blechman A, Greco MA, Alfonso F, Demopoulos RI. Lymphoma of ovary with stromal luteinization, presenting as secondary amenorrhea. Gynecologic Oncology. 1992; 45: 69 75.
23. Mittal KR, Goswami S, Demopoulos RI. Patterns of keratin 19 expression in normal cervix, cervical dysplasia, condylomas, squamous metaplasia, atrophy, and invasive carcinoma. Am J Clin Path. 1992; 98: 419 423.
24. Mittal KR, Zeleniuch Jacqotte A, Cooper J, Demopoulos RI. Contralateral ovary in unilateral ovarian carcinoma : A search for pre neoplastic lesions. Int J Gynecol Pathol. 1993; 12: 59 63.
25. Mittal KR, Goswami S, Demopoulos RI. Proliferating Cell Nuclear Antigen expression in normal and abnormal cervical squamous epithelia. Am J Surg Pathol. 1993; 17: 117 122.
26. Moritz M, Lundquist K, Juan PP, et al. Rapid development of Lymphoma following Liver transplant in a recipient with Hepatitis B and Hemochromotosis. Am J Gastroentrology. 1993; 88: 102 104.
27. Koenig C, Vamvakas EC, Mittal KR, Feiner HD, Esperitiu EC Demopoulos RI. Flow cytometric DNA ploidy and quantitative histopathology in partial moles. Int J Gynecol Pathol. 1993; 12(3): 235 240.
28. Mittal KR, Barwick KW. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades and excellent prognosis. Gynecol Oncol. 1993; 49(2): 197 201.
29. Persaud D, Bangaru B, Greco A, et al. Fulminant Hepatitis in children infected with the Human Immunodeficiency Virus. Ped Inf Dis. 1993; 12: 402 408.
30. Roland JT, Rothstein SG, Mittal KR, Persky MS. Squamous Cell Carcinoma in HIV positive patients under age 45. Laryngoscope. 1993; 103(5): 509 511.
31. Gold LI, Saxena B, Mittal K, Goswami S, Korc M, Demopoulos RI. Increased expression of TGF beta isoforms and bFGF in complex hyperplasia and adenocarcinoma of the endometrium : evidence for paracrine and autocrine action. Cancer Res. 1994; 54: 2347 2358.
32. Mittal KR, Goswami S, Demopoulos RI. Immunohistochemical profile of Ovarian inclusion cysts in patients with and without ovarian carcinoma. The Histochemical Journal. 1995; 27: 119 122.
33. Mittal KR, Peng XC, Wallach RC, Demopoulos RI. Co existent Atypical Polypoid Adenomyoma and Endometrial Adenocarcinoma. Hum Pathol. 1995; 26: 574 576.
34. Mittal K, Lin O, Demopoulos RI, Goswami S, Chan W. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV. Gyn Oncol. 1995; 58: 289 294.
35. Marcelli A, Demopoulos R, Goswami S, Mittal K. Comparison of p53 and MIB1 in benign and borderline areas of Ovarian serous tumors. Int J Gynecol Pathol. 1996; 15: 39 44.
36. Palazzo JP, Mittal KR. Lymphoepithelioma like carcinoma of the rectum in a patient with ulcerative colitis. Am J Gastroentrology. 1996; 91(2): 8 9.
37. Demopoulos R, Genega B, Vamvakas E, Carlson E, Mittal K. Papillary carcinoma of Endometrium : Morphometric predictors of survival. Int J Gynecol Pathol. 1996; 15: 110 118.
38. Mittal K, Schwartz L, Gooswami S, Demopoulos R. Estrogen and Progesterone receptor expression in endometrial polyps. Int J Gynecol Pathol. 1996; 15: 345-348.
39. Schwartz L, Krey L, Demopoulos R, Natchtigall LE, Goldstein S, Mittal K. Alterations in steroid receptors in the Tamoxifen treated endometrium. Am J Obstet Gynecol. 1997; 1176: 129-137.
40. Mesia AF, Gahr D, Wild M, Mittal K, Demopoulos RI. Immunohistochemistry of vascular changes in Tamoxifen treated leiomyomata. Am J Obstet Gynecol. 1997; 176: 1026-1029.
41. Demopoulos R, Jones K, Mittal K, Vamvakas E. Histology of leiomyomata in patients treated with Leuprolide acetate. Int J Gynecol Pathol. 1997; 16: 131-137.
42. Morkrzycki M, Mittal K, Smilen SW, Blechman AN, Porges RF, Demopoulos, RI. Estrogen and progesterone receptors in the uterosacral ligament. Obstet Gynecol. 1997; 90: 402-404.
43. Mittal K, Demopoulos RI, Tata M. Comparison of proliferative activity and atypical mitoses in cervical condylomas with various Human Papillomavirus types. Int J Gynecol Pathol. 1998; 17: 24-28.
44. Cuesta KH, Palazzo JP, Mittal K. Detection of Human papillomavirus in verrucous carcinoma from HIV-positive patients. J Cutan Pathol. 1998; 25: 165-170.
45. Mittal K, Palazzo JP. Cervical condylomas show higher proliferation than do inflamed or metaplastic cervical squamous epithelium. Modern Pathology. 1998; 11: 780- 783.
46. Mesia AF, William FS, Yan Z, Mittal K. Aborting leiomyosarcoma after treatment with leuprolide acetate. Obstet Gynecol. 1998; 92: 664-666.
47. Schammel DP, Mittal KR, Kaplan K, Deligdisch L, Tavassoli FA. Endometrial adenocarcinoma associated with intrauterine pregnancy: A report of five cases and a review of literature. Int J Gynecol Pathol. 1998; 17: 327-335.
48. Mittal K, Mesia A, Demopoulos R. MIB-1 expression is useful in distinguishing dysplasia from atrophy in elderly women. Int J Gynecol Pathol. 1999; 18: 122-124.
49. Demopoulos R, Mesia A, Mittal K, Vamvakas E. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: Clues to pathogenesis. Int J Gynecol Pathol. 1999; 18: 233-237.
50. Mittal K. Utility of proliferation associated marker MIB-1 in evaluating lesions of the uterine cervix. Adv Anat Pathol. 1999; 6: 177-185.
51. Lee CC, Ylagan LR, Mittal K. Emergency Department presentation of abdominal pain misdiagnosed as appendicitis. Am J Emer Med. 1999; 17: 614-615.
52. Mittal K. Utility of MIB-1 in evaluating cauterized cone biopsy margins. Int J Gynecol Pathol. 1999; 18: 211-214.
53. Cubukcu Dimopulo O, Greco A, Kumar A, Karluk D, Mittal K, Jagirdar J. BK virus infection in AIDS. Am J Surg Pathol. 2000; 24(1): 145 149.
54. Mittal K, Papiolek D, Demopoulos RI. Uterine myxoid leiomyosarcoma within a leiomyoma. Hum Pathol. 2000; 31: 398-400.
55. Del Priore G, Williams R, Harbatkin CB, Wan LS, Mittal K, Yang CH. Endometrial brush biopsy for the diagnosis of endometrial cancer. J Reprod Med. 2001; 46: 439-443.
56. Levine HP, Abou-Nassar S, Mittal K. Extrauterine low grade endometrial stromal sarcoma with florid endometrioid glandular differentiation. Int J Gynecol Pathol. 2001; 20: 395-398.
57. Zeleniuch Jacqotte A, Akhmedkhanov A, Kato I, et al. Postmenopausal endogenous estrogen levels and risk of endometrial cancer: results of a prospective study. British Journal of Cancer. 2001; 84: 975-981.
58. Mittal K, Demopoulos RI. MIB-1, p53, ER and PR expression in uterine smooth muscle tumors. Hum Pathol. 2001; 32: 984-987.
59. Zeng Z, Delpriori G, Cohen JM, Mittal K. MIB-1 Expression in Cervical Pap Smears Correlates with Dysplasia in Subsequent Cervical Biopsies. Applied Immunohistochemistry and Molecular Morphology. 2002; 10: 15-19.
60. Levine P, Mittal K. Rhabdoid Epithellioid Leiomyosarcoma of the Uterine Corpus. Int J Surg Pathol. 2002; 10: 231-236.
61. Levine P, Waisman J, Mittal K. Significance of the cytologic diagnosis of endocervical glandular involvement in high-grade squamous intraepithelial lesions. Diagn Cytopathol. 2002; 26: 217-221. doi: 10.1002/dc.10077
62. Hines BJ, Porges RF, Mittal K, Muggia FM, Curtin JP. Use of medroxyprogesterone acetate in the treatment of Mullerian adenosarcoma: a case report. Gynecol Oncol. 2002; 85: 192-195. doi: /10.1006/gyno.2002.6585
63 Hummel Levine P, Elgert PA, Mittal K. False positive squamous cell carcinoma in cervical smears: cytologic-histologic correlation in 19 cases. Diagn Cytopathol. 2003; 28: 23-27. doi: 10.1002/dc.10220
64. Qiu W, Mittal K. Comparison of Morphologic and Immunostaining Patterns of Cervical Microglandular Hyperplasia with Mucinous Adenocarcinoma of the Endometrium. Int J Gynecol Pathol. 2003; 22: 261-265.
65. Levine PH, Wei XJ, Gagner JP, Flax H, Mittal K, Blank SV. Pleomorphic liposarcoma of the uterus: case report and literature review. Int J Gynecol Pathol. 2003; 22: 407-411.
66. Ventura KC, Popiolek D, Mittal K. Endometrial Adenocarcinoma In-Situ in Complex Atypical Hyperplasia: Correlation with Findings in Subsequent Hysterectomy Specimen. Int J Surg Path. 2004; 12: 225-230. doi: 10.1177/106689690401200303
67. Popiolek D, Ventura KC, Mittal K. Distinction of low-grade squamous intraepithelial lesions from high-grade squamous intraepithelial lesions based on quantitative analysis of proliferative activity. Oncol Rep. 2004; 11: 687-691. doi: 10.3892/or.11.3.687
68. Yin H, Mittal K. Incidental findings in uterine prolapse specimen: frequency and implications. Int J Gynecol Pathol. 2004; 23: 26-28.
69. Mittal K. The nine lives of beta-Catenin. (Editorial). Hum Pathol. 2004; 35: 647-648. doi: 10.1016/j.humpath.2004.04.006
70. Wei J, Chiriboga L, Mizuguchi M, Yee H, Mittal K. Expression profile of Tuberin and Some Potential Tumorigenic Factors in 60 Patients with Uterine Leiomyomata. Mod Path. 2005; 18: 179-188. doi: 10.1038/modpathol.3800283
71. Gagner JP, Mittal K. Malignant mixed Müllerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma. Gynecol Oncol. 2005; 97: 219-222. doi: 10.1016/j.ygyno.2004.11.053
72. Arslan A, Gold LI, Mittal K, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyomata: new evidence and a systematic review. Hum Reprod. 2005; 20: 852-863. doi: 10.1093/humrep/deh698
73. Popiolek DA, Kumar AR, Mittal K. Large cell variant of small cell carcinoma, hypercalcemic type, of primary peritoneal origin. Gynecol Oncol. 2005; 96: 249-253. doi: 10.1016/j.ygyno.2004.09.040
74. Fetsch PA, Abati A, Litman T, et al. Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Lett. 2005; XX: 1-9.
75. Wei J, Chiriboga L, Mittal K. Expression profile of the tumorigenic factors in association with tumor size and sex steroid hormone status in uterine leiomyomata. Fertil Steril. 2005; 84: 474-484. doi: 10.1016/j.canlet.2005.04.024
76. Wei JJ, Zhang X, Chiriboba L, Yee H, Mittal K. Large Uterine Leiomyomata: Spatial Differences in Biological Activity. Fertil Steril. 2006; 85: 179-187.
77. Wei JJ, Melamed J, Chiriboba L, Yee H, Mittal K. Ethnic Differences in Expression of the Dysregulated Proteins in Uterine Leiomyomata. Hum Reprod. 2006; 21: 57-67.
78. Charles NC, Lisman RD, Mittal K. Carcinoma of the lacrimal canaliculus masquerading as canaliculitis. Arch Opthalmol. 2006; 124: 414-416. doi: 10.1001/archopht.124.3.414
79. Mittal K. Differences in mitotic activity may explain observed differences in HIF-1 alpha response in cancers and stroma. PLoS Med. 2006; 3(8): e370. doi: 10.1371/journal.pmed.0030370
80. Popiolek DA, Yee H, Mittal K, et al. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol. 2006; 37(11): 1426-1434.
81. Liang J, Mittal KR, Wei JJ, Yee H, Chiriboga L, Shukla P. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. Int J Gynecol Pathol. 2007; 26(1): 71-75.
82. Mittal K , Joutovsky A. Areas with Benign Morphologic and Immunohistochemical features are associated with some Uterine Leiomyosarcomas. Gynecol Oncol. 2007; 104(2): 362-365. doi: 10.1016/j.ygyno.2006.08.034
83. Wang T, Zhang X, Obijuru L, et al. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer. 2007; 46(4): 336-347.
84. Lecanda J, Parekh TV, Gama P, et al. Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium. Cancer Res. 2007; 67(3): 1007-1018.
85. Sebenik M, Yan Z, Mittal K. Malignant Mixed Mullerian Tumor of the Vagina. Case report with review of the literature, immunohistochemical study and evaluation for human papilloma virus. Hum Pathol. 2007; 38: 1282-1288.
86. Levy M, Mittal K, Chiriboga L, Zhang X, Yee H, Wei JJ. Differential expression of selected gene products in uterine leiomyomata and adenomyosis. Fertil Steril. 2007; 88(1): 220-223. doi: 10.1016/j.fertnstert.2006.11.104
87. Mittal K, Soslow R, McCluggage W. Application of Immunohistochemistry to Gynecologic Pathology. Arch Pathol Lab Med. 2008; 132(3): 402-423. doi: 10.1043/1543-2165(2008)132[402:AOITGP]2.0.CO;2
88. Mittal K, Da Costa D. Endometrial Hyperplasia and Carcinoma in Endometrial Polyps: Clinico-Pathologic And Follow-Up Findings. Int J Gynecol Pathol. 2008; 27(1): 45-48.
89. Peng Y, Laser J, Shi G, Mittal K, Lee P, Wei JJ. Anti-proliferative effects by let-7 repression of high-mobility group A2 in uterine leiomyoma Mol Cancer Res. 2008; 6(4): 663-673.
90. Peng L, Wen Y, Han Y, et al. Expression of Insulin-Like Growth Factors (IGFs) and IGF signaling: Molecular Complexity in Uterine Leiomyomas. Fertil Steril. 2009; 91(6): 2664-2675.
91. Shi G, Perle MA, Mittal K, et al. Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma. J Cell Mol Med. 2009; 13(9B): 3898-3905.
92. Mittal K, Sebenik M, Irwin C, et al. Presence of Endometrial Adenocarcinoma-In-Situ in Complex Atypical Endometrial Hyperplasia is Associated with Increased Risk of Endometrial Adenocarcinoma in Subsequent Hysterectomy. Mod Pathol. 2009; 22: 37-42.
93. Morse DE, Psoter WJ, Cuadrado L, et al. A deficit in the detection of pre- and very early oral cancers in Puerto Rico. Cancer Detect Prev. 2009; 32(5-6): 424-430.
94. Mittal K, Chen F, Wei JJ, et al. Molecular and Immunohistochemical Evidence for Origin of Uterine Leiomyosarcomas from Associated Leiomyoma and Symplastic Leiomyoma Like Areas. Mod Pathol. 2009; 10: 1303-1311.
95. Sun X, Mittal K. MIB-1 (Ki-67), Estrogen Receptor, Progesterone Receptor and p53 Expression in Atypical Cells in Uterine Symplastic Leiomyomas. Int J Gynecol Pathol. 2010; 29: 51-54.
96. Tsai MC, Gulyaeva L, Segel S, Maxwell E, Mittal K. Atypical presentation of a ruptured appendiceal mucinous cystadenoma diagnosed postoperatively. Journal of Gynecologic Surgery. 2010; 26(3): 219-221.
97. Park H, Pagan L, Tan O, et al. Estradiol Regulates Expression of Polysialated Neural Cell Adhesion Molecule by Human Vascular Endothelial Cells. Reprod Sci. 2010; 17(12): 1090-1098. doi: 10.1177/1933719110379649.
98. Mailath-Pokorny M, Timor-Tritsch IE, Monteagudo A, Mittal K, Konno F, Santos R. Prenatal diagnosis of unilateral proximal femoral focal deficiency (PFFD) at 19 gestational weeks: A case report and review of literature. Ultrasound Obstet Gynecol. 2011; 38(5): 594-597.
99. Hale C, Lee L, Mittal K. Triple Synchronous Primary Gynecologic Carcinomas: a case report and review of the literature. Int J Surg Pathol. 2011; 19(4): 552-555. doi: 10.1177/1066896911409579
100. Nair N, Curtin JP, Mittal K, Hiotis KL. Cervical adenocarcinoma in a patient with Lynch Syndrome, Muir Torre variant. J Clin Oncol. 2012; 30(2): e5-e6. doi: 10.1200/JCO.2011.36.3325
101. Huang KT, Pavlides SC, Lecanda J, Blank SV, Mittal KR, Gold LI. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer. PLoS One. 2012; 7(9): e46072.
102. Lewin S, Dezube D, Guddati A, Mittal K, Muggia F, Klein P. Paraneoplastic Hypercalcemia in Clear-Cell Ovarian Adenocarcinoma. E cancer medical science. 2012; 6: 271. doi: 10.3332/ecancer.2012.271
103. Charles N, Marr BP, Stenson S, Mittal K. Pigmented Viral-Associated Conjunctival Carcinoma. Case Reports in Ophthalmological Medicine. 2013; 2013: 783104. doi: 10.1155/2013/783104
104. Guijarro MV, Dahiya S, Danielson LS, et al. Dual Pten/p53 suppression promotes sarcoma progression by triggering Notch signaling. Am J Pathol. 2013; 182(6): 2015-2027. doi: 10.1016/j.ajpath.2013.02.035
105. Hurst PV, Nicosia MJ, Datkhaeva I, Mittal KR, Tsai MC. Echogenic Uterine Fluid Collection as an Unusual Presentation of Endometrial Squamous Metaplasia. Journal of gynecologic surgery. 2013; 29(3): 148-150. doi: 10.1089/gyn.2012.0103
106. Pavlides SC, Huang KT, Reid DA, et al. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Endocrinology. 2013; 154: 4030-4034. doi: 10.1210/en.2013-1757
107. Bertsch E, Qiang W, Zhang Q, et al. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol. 2014; 27: 1144-1153. doi: 10.1038/modpathol.2013.243
108. Timor-Tritsch IE, Monteagudo A, Cali G, et al. Cesarean scar pregnancy and early placenta accreta share a common histology. Ultrasound in obstetrics & gynecology. 2014; 43: 383-395. doi: 10.1002/uog.13282
109. Mittal K, Salem A, Lo A. Diagnostic criteria for distinguishing endometrial adenocarcinoma from complex atypical endometrial hyperplasia. Hum Pathol. 2014; 45: 98-103. doi: 10.1016/j.humpath.2013.08.009
110. Harrison BT, Berg RE, Mittal K. Massive ovarian edema associated with a broad ligament leiomyoma: a case report and review. International journal of gynecological pathology. 2014; 33: 418-422. doi: 10.1097/PGP.0b013e31829d76ee
111. Harrison BT, Mittal K. Morphologic Features Suggestive of Endometriosis in Nondiagnostic Peritoneal Biopsies. Int J Gynecol Pathol. 2015; 34: 507-516. doi: 10.1097/PGP.0000000000000196